Skip to main content

The news desk

AI news, checked against the source.

What changed in AI, one story at a time. Each one links to its primary source, and facts stay apart from interpretation.

Last updated ·

Wednesday, October 21UTC

  1. New
    Coherence NeuroFundingFunding & Deals

    Coherence Neuro says investors backed its AI-enabled cancer-device work with $45 million

    Coherence Neuro says Founders Fund and the OpenAI Startup Fund backed it with $45 million to develop implantable devices and algorithms that could monitor tumor changes. Its original research account describes preclinical mouse-model results and early human device testing; adaptive cancer treatment and regulatory designation remain goals, not established clinical benefits. The company does not state a valuation.

    Coherence Neuro2 sources

Free, email only

Unlock the full brief free.

  • Thirty days of stories to browse, not seven
  • On every story: what to check, each source and why it matters
  • The same signup unlocks every free tool
Continue with Google and subscribeContinue with Apple and subscribe

Continuing subscribes the email on that account to Work Worth Doing, my newsletter, the same as the form below, and unlocks every free tool in this browser. We only receive your email address. Unsubscribe in one click.

This is not an account: there is no password, and the unlock is a cookie in this browser. You also join Work Worth Doing, Demetri Panici's newsletter, every week: what I built and what changed in AI. We'll email you a link to confirm, and you can unsubscribe in one click. The same signup unlocks every free tool on the site. How your email is handled.

Already subscribed? Enter the same email to unlock this browser. You won't be signed up twice.

Days are UTC. Some sources report an exact time and others only a date; both are placed on their UTC day.